Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jesper Graakjær

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
European Journal of Medical Genetics|November 17, 2011
Further delineation of 17p13.3 microdeletion involving CRK. The effect of growth hormone treatmentJohn R Østergaard, Jesper Graakjær, Carsten Brandt, et al.
Ugeskrift for Laeger|June 25, 2021
[Incontinentia pigmenti in a newborn boy]Kristin Bergmann, Pernille Aléx Gregersen, Jesper Graakjær, et al.
Neurobiology of Disease|August 25, 2019
Perturbations in RhoA signalling cause altered migration and impaired neuritogenesis in human iPSC-derived neural cells with PARK2 mutationHelle Bogetofte, Pia Jensen, Justyna Okarmus, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
European Journal of Medical Genetics|November 17, 2011
Further delineation of 17p13.3 microdeletion involving CRK. The effect of growth hormone treatmentJohn R Østergaard, Jesper Graakjær, Carsten Brandt, et al.
Ugeskrift for Laeger|June 25, 2021
[Incontinentia pigmenti in a newborn boy]Kristin Bergmann, Pernille Aléx Gregersen, Jesper Graakjær, et al.
Neurobiology of Disease|August 25, 2019
Perturbations in RhoA signalling cause altered migration and impaired neuritogenesis in human iPSC-derived neural cells with PARK2 mutationHelle Bogetofte, Pia Jensen, Justyna Okarmus, et al.
Pageof 1